AstraZeneca vs Johnson & Johnson

AstraZeneca (Data and AI: Unlocking new science insights) and Johnson & Johnson both appear on the Smoower Developer Ecosystem Index.

AstraZeneca (rank #510) holds a narrow lead over Johnson & Johnson (rank #602) on the overall Smoower ecosystem score (37 vs 34). The gap of 3 points reflects composite signals across code, docs, community and reach.

On code quality (the state of repositories, tests, releases and polish), AstraZeneca is slightly ahead of Johnson & Johnson. On education (docs, guides and learning material for developers), AstraZeneca is clearly ahead of Johnson & Johnson. On reach (how visible the ecosystem is beyond its own repos), Johnson & Johnson is ahead of AstraZeneca. On momentum (release cadence and how fast the ecosystem moves), AstraZeneca is ahead of Johnson & Johnson.

AstraZeneca carries 5,180 GitHub stars across 107 public repos, with 22 repositories active in the last 90 days and 2 external contributors on record. Johnson & Johnson shows 168 stars across 48 public repos, 8 active in the last 90 days and 1 external contributors. The star gap on its own does not decide the comparison, but AstraZeneca's footprint is roughly 30.8x larger, which usually shows up in downstream signals like inbound issues and third party integrations.

AstraZeneca is the stronger read for anyone weighting education. Johnson & Johnson looks better where reach is the deciding factor. The table below breaks the scores down pillar by pillar; the linked profiles cover the underlying repos, docs and community signals in full.